Skip to main content

Want a detailed portfolio tracker?

PHAXIAM Therapeutics SA ADR (PHXM) P/E (2023 - 2026)

PHAXIAM Therapeutics SA ADR (PHXM) P/E from Jun 29, 2023 to Jun 3, 2026. The TTM PHAXIAM Therapeutics SA ADR (PHXM) P/E is -1.63. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of PHAXIAM Therapeutics SA ADR (PHXM)

YearP/EChange
2026-1.63+825.77%
2023-0.18N/A

Comparison PHAXIAM Therapeutics SA ADR (PHXM) P/E with competitors

PHAXIAM Therapeutics SA ADR (PHXM) P/E is -1.63.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.10%
NBYStablecoin Development Corp0.10-106.26%
ENLVEnlivex Therapeutics Ltd0.15-109.19%
FGENFibroGen Inc0.24-114.69%
TRAWTraws Pharma Inc0.47-128.93%
FBIOFortress Biotech Inc0.71-143.20%
CHRSCoherus Biosciences Inc0.98-159.85%
ORMPOramed Pharmaceuticals Inc1.47-190.16%
AGENAgenus Inc2.05-225.35%
VIVSVivoSim Labs Inc2.54-255.16%
INVAInnoviva Inc3.19-295.10%
CRMDCorMedix Inc3.65-323.08%
ABEOAbeona Therapeutics Inc4.20-357.31%
VXRTVaxart Inc4.26-360.77%
CVACCureVac N.V.4.45-372.03%
SRPTSarepta Therapeutics Inc4.62-382.96%
GLPGGalapagos NV4.86-397.31%
RIGLRigel Pharmaceuticals4.92-401.03%
ZVRAZevra Therapeutics Inc4.97-404.36%
ABUSArbutus Biopharma Corp5.69-448.40%
CGENCompugen Ltd7.38-551.83%
AUPHAurinia Pharmaceuticals Inc9.25-666.11%
ACADAcadia Pharmaceuticals Inc9.59-686.70%
OMEROmeros Corporation9.88-704.78%
PLXProtalix BioTherapeutics Inc9.91-706.35%
SPROSpero Therapeutics Inc10.73-756.87%
ADMAAdma Biologics Inc11.33-793.34%
SVASinovac Biotech Ltd11.44-799.79%
TBPHTheravance Biopharma Inc11.78-820.63%
HRMYHarmony Biosciences Holdings Inc12.18-845.34%
TGTXTG Therapeutics Inc13.18-906.47%
INCYIncyte Corp13.38-918.87%
SABSSAB Biotherapeutics Inc14.06-960.21%
XOMAXOMA Corp14.95-1014.52%
REGNRegeneron Pharmaceuticals Inc14.98-1016.66%
PBYIPuma Biotechnology Inc15.05-1020.96%
EXELExelixis Inc15.79-1066.51%
NAGENiagen Bioscience Inc16.35-1100.78%
CPRXCatalyst Pharmaceuticals Inc17.34-1161.35%
MDXGMimedx Group Inc17.38-1163.22%
ARGXArgen X SE23.07-1511.79%
HALOHalozyme Therapeutics Inc23.20-1519.68%
XOMAOXOMA Corp25.34-1650.89%
VRTXVertex Pharmaceuticals Inc25.66-1669.92%
XOMAPXOMA Corp25.67-1670.79%
CTMXCytomX Therapeutics Inc25.70-1672.49%
ASNDAscendis Pharma A/S26.35-1712.65%
RPRXRoyalty Pharma plc - Class A27.50-1782.49%
SLNOSoleno Therapeutics Inc29.02-1875.49%
LGNDLigand Pharmaceuticals Inc - Class B30.19-1947.16%
BMRNBiomarin Pharmaceutical Inc37.51-2395.13%
APLSApellis Pharmaceuticals Inc39.02-2487.77%
KRYSKrystal Biotech Inc39.70-2529.16%
GMABGenmab40.20-2560.12%
ONCBeiGene Ltd67.03-4201.49%
TECHBio-Techne Corp68.59-4297.44%
VCELVericel Corp80.63-5033.84%
ALNYAlnylam Pharmaceuticals Inc124.93-7744.90%
TLXTelix Pharmaceuticals Ltd139.89-8660.14%
CORTCorcept Therapeutics Inc158.39-9792.11%